In the framework of gene expression data analysis, the selection of biologically relevant sets of genes and the discovery of new subclasses of diseases at bio-molecular level represent two significant problems. Unfortunately, in both cases the correct solution is usually unknown and the evaluation of the performance of gene selection and clustering methods is difficult and in many cases unfeasible. A natural approach to this complex issue consists in developing an artificial model for the generation of biologically plausible gene expression data, thus allowing to know in advance the set of relevant genes and the functional classes involved in the problem.
Introduction
DNA microarrays provide the gene expression level for thousands of genes pertaining to a given tissue, thus allowing to understand mechanisms regulating biological processes, such as the onset of a disease or the effects of a drug [2] . To this end, supervised and unsupervised machine learning and statistical methods have been largely applied to the analysis of gene expression data [14, 15, 20, 23] .
In some situations the quality of the solution offered by a given technique can be easily evaluated; this is the case of pattern recognition problems, where the accuracy of a classifier can be measured through cross-validation or holdout estimation. In other problems the performance of a statistic or learning method cannot be assessed since the correct solution is not available, even in a subset of cases.
For instance, several statistic and machine learning techniques [10, 11, 18] have been proposed in the literature to face with the important problem of gene selection, where the subset of genes involved in a biological process of interest is to be determined from a collection of microarray experiments. Unfortunately, the entire set of genes involved in a specific biological process is usually unknown or only partially known. Consequently, the evaluation of the real effectiveness of gene selection methods is very difficult and in many cases unfeasible.
Other important problems, such as the discovery of new subclasses of diseases detected at bio-molecular level may be formalized as unsupervised clustering problems [1, 19] . However, besides the fact that unsupervised clustering is in general an ill-posed problem, in this case no a priori solutions are known in advance, as the "real" bio-molecular classes are usually unknown.
To provide some kind of performance evaluation, several models have been proposed to produce synthetic gene expression data for classification, clustering and gene selection problems [6, 24] . Even if in principle they may be helpful to test gene selection methods, their main limitation consists in a drastic simplification of the model, which is not sufficiently rich to take into account the peculiarities of gene expression data.
In this paper we propose a new biologically motivated mathematical model capable to describe the relationships between the expression levels of the genes of a virtual tissue and its functional state. In this way it is possible to design an artificial system for a genome-wide synthesis of gene expression data. In particular, the randomness due to biological variability and measurement errors is gathered in a specific term, whereas it is shown that the deterministic part of the model can be implemented by a positive Boolean function acting on relevant genes.
Furthermore, a convenient manner of writing this kind of functions consists in employing m-of-n expressions, which are able to capture the main biological characteristics of gene expression, while maintaining a sufficient simplicity. Numerical experiments show how to apply the proposed model to the analysis of the performances of largely used statistical and machine learning gene selection methods.
The structure of the paper is the following: Sec. 2 analyzes in details the biological characteristics of gene expression data that must be taken into account in the development of an artificial model for the generation of virtual microarray experiments. The proposed model based on positive Boolean functions is described in Sec. 3, whereas in Sec. 4 numerical experiments show how to apply the proposed model to the perfomance analysis of gene selection methods. Sec. 5 reports some conclusions.
Biological characteristics of gene expression data
Many important results published in the bio-medical and bioinformatics literature point out the main structures underlying gene expression data. Their analysis allows to derive a collection of specific characteristics, which must be satisfied by an artificial model so as to produce biologically plausible gene expression levels.
Profiles and expression signatures
The main goal of gene selection methods consists in finding sets of genes significantly related to a specific functional state (e.g. diseased vs. healthy). In the bio-molecular literature sets of biologically relevant and differentially expressed genes are named expression signatures [1, 7, 16, 17, 26] . This term has been firstly introduced by Alizadeh et al. [1] to characterize gene expression patterns found by gene expression profiling. More precisely this term refers to a group of genes coordinately expressed in a given set of specimens and in a specific physiological or pathophysiological condition.
The correlation among the mRNA levels of the genes is due to the underlying regulatory system, by which the same set of transcription factors and binding sites may be directly or indirectly shared by the genes belonging to the same expression signature. Hence, a gene expression signature indicates a cluster of coordinately expressed genes, whose coordination reveals the fact that they participate to the same biological process (and hence they are controlled by the same set of regulation factors). Indeed, they are usually named by either the cell type in which their component genes are expressed, or by the biological process in which their component genes are known to function.
From this standpoint the overall expression profile of a patient can be interpreted as a collection of gene expression signatures that reveal different biological features of the analyzed sample [1] .
Expression signatures has been mainly discovered and analyzed in gene expression profiles of diseases. For instance, the expression profiling of B-cell malignancies through hierarchical clustering revealed expression signatures related to cell-proliferation, lymph-nodes, T-cells, Germinal Center B-cells (GCB) and others [1] .
Independent Component Analysis performed on gene expression data from ovarian cancer tissues found gene expression signatures representing potential pathophysiological processes in ovarian tissue samples [16] . Expression profiling of rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, identified two signatures associated with metastatic RMS, responsible for most of the fatal outcome of this disease [26] , while two way hierarchical clustering analysis identified several expression signatures expressed in different types of bladder carcinoma [7] .
Expression signatures have been also identified in species other than humans and in contexts not related to tumoral differentiation. For instance comparative functional genomics based on shared patterns of regulations across orthologous genes identified shared expression signatures of aging in orthologous genes of D. melanogaster and C. elegans [17] .
Since expression profiles and expression signatures seem to be well-established biological structures that characterize gene expression data, they can be employed as the corner stones of our artificial model. To this aim, in the next subsection the main properties of gene expression signatures will be analyzed and discussed.
Characteristics of gene expression signatures
Differential expression and co-expression. Differential expression analysis of single genes, even if it may be useful to identify specific genes involved in biological processes [5] , cannot capture the complexity of tightly regulated processes, crucial for the proper functioning of a cell. Correlations among gene expression levels have been observed [1, 8] , reflecting the fact that in most biological processes genes are co-regulated. As recently observed, not all the changes in co-regulation are manifested by up or down regulation of individual genes, and we need to explicitly consider interactions among genes to discover patterns in the data [13] . This corresponds to examine sets of co-regulated genes, i.e. expression signatures, to reveal functional relationships among genes.
Gene expression signatures as a whole rather than single genes contain predictive information. Many times is the signature taken as a whole that seems to contain predictive information for a biologically meaningful identification of tissue samples. For instance, it was found an expression signature of 8 upregulated and 9 downregulated genes associated with metastasis in different types of adenocarcinoma: none of these genes represents a marker, but it is the signature as a whole that represents a "collective marker" of tumor metastasis [21] . In other works [13, 21] it has been shown that in some cases relevant differences are subtle at the level of individual genes but coordinate in gene expression groups.
Genes may belong to different gene expression signatures at the same time. Many genes may be involved in a number of distinct behaviors, depending on the specific conditions of the tissue. From this standpoint they may belong to different expression signatures [9] . Indeed, each gene may be influenced by several transcription factors, each of which affects several genes [16] . Moreover, many underlying conditions in a given sample may concur to define a gene expression signature (e.g. tumorigenesis, angiogenesis, apoptosis) [12] .
Expression signatures may be independent of clinical parameters. An expression signature of 153 genes can be used to correctly classify hepatocellular carcinoma (HCC) intra-hepatic metastasis from metastatic-free HCC [25] . This expression signature, that embeds high predictive information, has been shown to be independent of tumor size, tumor encapsulation and patient age, but very similar to that of their corresponding metastases. Several other works showed that a bio-molecular characterization of tumors can discover different subtypes of malignancies, not detectable with traditional morphological and histopathological features (see e.g. [1, 10] ).
Different gene expression profiles may share signatures and may differ only for few signatures. It has been shown that gene expression signatures may be shared and partially expressed in different gene expression profiles [1, 21, 25] . For instance, it has been shown that Diffuse Large B-Cell Lymphoma (DL-BCL) subgroups (GCB-like and activated B-like DLBCL) share most of the expression signatures but differ mainly for two signatures (GCB and activated B-cell signatures), partially expressed respectively in germinal center B-cell and activated peripheral blood B cell [1] .
Moreover, hierarchical clustering, in the space of a 128 genes signature of metastatic adenocarcinoma nodules of diverse origin, showed two clusters of primary tumors that were highly correlated with metastatic ones: this fact, together with a differential overall survival in primary adenocarcinoma tumors, showed that the considered gene expression signature is present in a subpopulation of primary tumors [21] .
Hence, gene expression profiles of functionally different tissues may share some expression signatures, differing only for a subset of them. These expression signatures may be also partially expressed (that is, not all the genes belonging to the expression signature are over-expressed or under-expressed), reflecting functional alterations in diseased patients.
Modeling issues
In the light of the characteristics of gene expression signatures described in the previous section, we can identify the following main issues, which must be taken into account in the construction of a biologically plausible artificial model for gene expression data:
(1) Expression profiles may be characterized as a set of gene expression signatures, which uniquely determines a functional group of samples. Thus, the model should allow us to define expression profiles in terms of expression signatures, ensuring a large flexibility with respect to the number and the kind of genes composing the synthetic expression signatures. (2) Expression signatures are interpreted in the literature as a set of coexpressed genes; these genes may be overexpressed or underexpressed with respect to a particular condition. Accordingly, in the model, each expression signature should be defined as a set of overexpressed or underexpressed genes, that is genes with expression levels above or below a given threshold. The model should define a signature active if its genes are coordinately over(under)expressed. (3) Expression signatures may be defined either by the overall available knowledge about bio-molecular processes (e.g. by Gene Ontology categories) or may be discovered through statistical and machine learning methods. Hence, the model should permit to define arbitrary signatures, in order to face with a large range of applications in different biological contexts. (4) Genes may belong to different signatures at the same time. Consequently, the model should allow to assign the same gene to different signatures. (5) The number of genes within an expression signature usually vary from few units to few hundreds. Accordingly, the model should permit to select within this range the number of elements for each gene expression signature. (6) Apart from technical variation (that in principle should be detected and canceled by proper design and implementation of bio-technological experiments and suitable pre-processing procedures [3] ), gene expression is biologically variable also within functional classes (conditions) [4] . Thus, the model should reproduce the variation of gene expression data, which may be simulated by sampling from a predefined distribution. Our preliminary analysis showed that gene expression values are close to be normally distributed. Since in a real situation, due to both biological variability and possible measurement errors occurring in DNA-microarray experiments, a deterministic relationship between gene expression values and the functional state of the tissue does not exist, the model will be composed by a deterministic part described through a function f : R m → {0, 1} and by a random term e corresponding to the probability that a tissue is assigned to the wrong state. If we denote with y the output of the model and with x the input vector we will have
f (x) with probability 1 − e 1 − f (x) with probability e To define the model function f let us introduce the input set A = {g 1 , . . . , g m }, given by the collection of the total number m of analyzed genes, and the real vector x = (x 1 , . . . , x m ) including the expression levels of the m genes belonging to A.
Suppose that, for each gene g i belonging to A, a modulation threshold t i exists so that we can assert that the gene g i is overexpressed if the value x i of its expression exceeds t i and underexpressed if x i < −t i . More precisely, we say that a gene is modulated when it is overexpressed or underexpressed with respect to a given functional state.
Therefore
Suppose the output is uniquely determined by the state (modulated or not) of the m genes and does not depend on their specific expression values. Then, the function f can be written as f (x) = ϕ(β(x)), where ϕ is a Boolean function defined on binary strings in {0, 1} m . Consequently, once the mapping β is completely described, the deterministic component f of our model is uniquely determined by the construction of the Boolean function ϕ. 
By using the definition of positive Boolean function it can be easily seen that p i ≥ p. Thus, we can denote with R ϕ the set of the indexes of the input components for which the strict inequality holds, i.e.
and with k = |R ϕ | its cardinality (number of elements). In a similar way we define
I ϕ will obviously have cardinality m − k and will include the indexes of the components of the input vector not relevant for the output. Hence, the function ϕ can be equivalently defined by a truth table with only k inputs; this new description leaves fractions p and p i unchanged.
As an example, consider the truth table in Tab. 1a for the positive Boolean function ϕ 1 . From a direct inspection, using the definitions (2), we obtain:
Since p 1 , p 2 and p 3 are strictly greater than p, whereas p 4 = p, the same function can be described by a truth table with 3 inputs, reported in Tab. 1b. As we can note, the values of p, p 1 , p 2 and p 3 remain unchanged.
It will be shown in this section that the adoption of a positive Boolean function ϕ for the construction of the model allows to satisfy the biological requirements outlined in Sec. 2. In particular, if gene g i (corresponding to the i-th input z i ) is defined to be relevant when p i > p, i.e. when i ∈ R ϕ , from a biological point of view, the set R ϕ determines the expression profile of the functional state described by ϕ, since the presence in it of indexes of modulated genes increases the probability that the corresponding tissue is in the considered functional state. The elements having indexes in I ϕ , on the contrary, are irrelevant for the determination of the output value for ϕ and, consequently, are associated with genes not belonging to the expression profile.
Consider a positive Boolean function and restrict its domain to include only the relevant k input variables. If D 1 (f ) is the collection of the input vectors z for which the output value of ϕ is 1
and P (z) is the set of the indexes of the components of z with value 1
we have
where P (z) is the logical product (and) among all the components of z with indexes in P (z), while D 1 is the logical sum (or) on the input vectors in D 1 .
In this way every positive Boolean function can be expressed through a logical sum ( ) of logical products ( ) of their inputs. As an example, consider the truth table in Tab. 1b: expression (3) for ϕ 1 has the form
An alternative way of representing a positive Boolean function can be derived by extending the concept of m-of-n expression defined in [22] . To this aim we introduce the following 
. . , h}, and p = 1. In this way the m-of-n expression of ϕ is equivalent to the and-or expression in (3) . 2
According to the proof of Th. 3, the function ϕ 1 of Tab. 1b can be put in the form of an m-of-n expression by taking the following two sets of components
each of them gives rise to a logical product in expression (4) since every set is active when all its components has value 1, i.e. when the corresponding logical product gives output 1. Then, by taking p = 1, the logical or in (4) is obtained.
In general, by denoting
we can represent ϕ as follows
As an example, from (5) we obtain:
However, this representation of ϕ 1 as an m-of-n expression is not unique; the same function can also be obtained by 
As a matter of fact, the resulting truth table, presented in Tab. 2, is equivalent to that reported in Tab. 1b.
The following example shows how, when the dimension k of the input domain is large, m-of-n expressions can provide a more compact description of positive Boolean functions with respect to (3).
Let ϕ 2 : {0, 1}
5
→ {0, 1} be the positive Boolean function having the truth table in Tab. 3. By using (3) we obtain:
However, it can be easily seen that the m-of-n expression
leads to the same positive Boolean function. Because of this property, m-of-n expressions will be employed to derive a compact representation for positive Boolean functions.
Finally, by combining the representation of the function ϕ defined in (6) and the mapping β defined in (1), the model function f (x) = ϕ(β(x)) can be written in an explicit form. It is sufficient to replace the components of the vector z belonging to the sets G i (q i ) with the mapping β that determines their values. For example, if z i assume value 1 when x i > t i , we can replace z i with x i > t i , otherwise we replace z i with x i < −t i . As an example, suppose 
, the mapping β has the following form
Then, by extending the representation (7), f 2 can be written as follows:
In this way, when a vector x is presented to the model, we can immediately know if f 2 (x) = 1. In addition, if we interpret each set G i (q i ) as an expression signature, it is easy to see that the proposed model implements the biological specifications presented in Sec. 2:
• The expression profile is defined in terms of expression signatures;
• Each expression signature is defined as a set of underexpressed or overexpressed genes, that is genes with gene expression levels above or below a given threshold; • Genes may belong to different expression signatures at the same time;
• By choosing a value of q lower than the cardinality of the sets G(q), not all the genes belonging to the expression signature have to be modulated to make G(q) active. In a similar way, by taking a value for p less than h, not all the expression signatures have to be active to induce the output value 1.
4 An application to the evaluation of gene selection methods
The model proposed in the previous section can be employed to evaluate the performance of gene selection methods in determining the correct set of relevant genes when analyzing a collection of examples derived from synthetic microarray experiments, each of which is associated with a virtual tissue. Every example is given by a pair (x, y), where x is a real-valued input vector whose components represent the gene expression levels for the corresponding tissue.
The output y can vary into a set of c different values, each one denoting the class which the associated tissue belongs to. In this way situations where the analyzed tissue belongs to one of c different possible classes are simulated; this corresponds to consider c different functional states, one for each output class. The case c = 2, where the output y can assume the values 1 and −1, will be examined henceforth; a generalization of the analysis to higher values of c is straightforward.
The mathematical model developed in the previous section can be adopted to describe each of the two functional states. Two subsequent phases have been devised: in the first one the two functions f 1 and f 2 , related to the two different functional states, are built, whereas in the second one the gene expression levels of n virtual tissues are generated.
As described in the previous section, randomness inherent the determination of the functional state can be collected into a real parameter e, so that with probability 1 − e each virtual tissue belonging to the output class 1 (resp. −1) has gene expression levels forming a vector x verifying f 1 (x) = 1 (resp. f 2 (x) = 1). If the classes are mutually exclusive (as it is usually the case), it should be guaranteed that each tissue belongs to only one functional state, i.e. if x is the associated input vector only one model provides the output 1.
The collection of virtual tissues generated by the model can be collected into a matrix X, where each row corresponds to a tissue and each column to a gene. Then, a final column Y representing the class of each tissue is added. Feature selection and clustering methods can be applied to Z = [X, Y ] and X respectively. However, since both the rule determining the membership of a tissue to a class and the relationship among the virtual genes are completely known, these methods can be directly tested and their performances can be easily evaluated.
As an example, we compare two feature selection methods, the technique proposed by Golub et al. in [10] (a simple variation of the classic t-test) and the SVM-RFE procedure [11] , on two different collections of examples built by adopting the model described in the previous section. The evaluation of the performances of the two methods has been performed by counting how many relevant genes, actually belonging to the expression profile, are found.
The first dataset X 1 is composed by 100 artificial tissues, 60 belonging to the first class and 40 in the second class, with 6000 virtual genes. The expression profiles of the two functional states, represented by the functions f 1 and f 2 , contain 144 genes in total.
The m-of-n expression of f 1 has been built by using the mathematical model described in the previous section with parameters:
while the values of the parameters for the function f 2 are the following:
• h = 6;
• l 1 = 14, l 2 = 12, l 3 = 13, l 4 = 11, l 5 = 11, l 6 = 10;
• q 1 = 7, q 2 = 6, q 3 = 7, q 4 = 6, q 5 = 6, q 6 = 5;
• p = 4;
For both the functional states the parameter e has been fixed to 0.1.
Both the Golub's method and SVM-RFE have been applied to the complete dataset
, being Y 1 the vector containing the labels y of the class of each tissue x (y = 1 if f 1 (x) = 1 or y = −1 if f 2 (x) = 1). Every gene selection method assigns a rank value to each of the 6000 genes: the higher is the rank the more relevant is the corresponding gene. The first 144 genes with greater rank values are then compared with the 144 genes actually belonging to the two expression profiles.
If we denote with G 144 and S 144 the set of the 144 most relevant genes selected by Golub's method and by SVM-RFE, respectively, we can evaluate the intersections between G 144 or S 144 and the set M 144 of the genes included in the two expression profiles. The greater is the size of the intersection, the better is the performance of the gene selection method. A relative measure of this term is given by the fraction P G (resp. P S ) of relevant genes contained in G 144 (resp. R 144 ).
The results show that The comparison between the values of P G and P S shows that in this artificial dataset the behavior of the Golub's method is significantly better than that of SVM-RFE. In particular, the former is able to retrieve most (92%) of the relevant genes.
The application of the same approach to a second artificial dataset may help to understand if this result has a more general validity. To this aim a new data matrix Z 2 = [X 2 , Y 2 ] has been generated, where X 2 contains 80 virtual tissues (50 belonging to the first class and 30 to the second class) and 2500 virtual genes. The parameters for the construction of the m-of-n expression f 1 for the first functional state are
• h = 5;
• l 1 = 13, l 2 = 17, l 3 = 10, l 4 = 17, l 5 = 10;
• q 1 = 6, q 2 = 7, q 3 = 4, q 4 = 7, q 5 = 4;
• p = 5;
while the model f 2 for the second functional state is generated starting from the following parameters
• l 1 = 12, l 2 = 15, l 3 = 12, l 4 = 10, l 5 = 12, l 6 = 10;
• q 1 = 5, q 2 = 6, q 3 = 5, q 4 = 4, q 5 = 5, q 6 = 4;
• p = 6;
The value of the parameter e has been fixed to 0.05.
Since, in this case, the total number of genes belonging to the two expression profiles is 133, we consider the sets G 133 and S 133 obtained by applying the Golub's method and SVM-RFE, respectively, to the dataset Z 2 and by taking the 133 genes with highest rank for both methods. In this way, we can again compute the quantities P G and P S , given by the fraction of relevant genes included in G 133 and S 133 : M 133 is the set of the relevant genes adopted for the construction of the m-of-n expressions of f 1 and f 2 . As one can note, also in this case the Golub's method achieves by far the best performance.
Conclusions
An artificial model for the generation of biologically plausible gene expression data, to be adopted in the evaluation of gene selection and clustering methods, has been proposed. Starting from the concepts of gene expression signature and gene expression profile, whose properties can be derived by publications in the bio-medical and bioinformatics literature, we have obtained a list of requirements that must be fulfilled by the artificial model to guarantee a sufficient degree of similarity between virtual and real gene expression data.
A mathematical model, composed by a random term and by a positive Boolean function ϕ, has been shown to satisfy the required specifications. The adoption of a particular form, called m-of-n expression, for the function ϕ allows to significantly simplify the generation process of the model, emphasizing the mathematical counterparts of gene expression signature and gene expression profile.
An application of the proposed artificial model in evaluating the performances of two gene selection techniques, Golub's method [10] and SVM-RFE [11] , has been also presented. The analysis of two artificial datasets, where the collection of relevant genes is considerably smaller than the whole set of genes characterizing the virtual tissue, has permitted to derive that the Golub's method performs significantly better than SVM-RFE, being able to retrieve more than 90% of the relevant genes.
